Recent Quotes (30 days)

You have no recent quotes
chg | %

ProMetic Life Sciences Inc.  

(Public, TSE:PLI)   Watch this stock  
Find more results for PLI
1.59
+0.02 (1.27%)
Oct 23 - Close
TSE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 1.55 - 1.61
52 week 0.75 - 1.84
Open 1.55
Vol / Avg. 711,482.00/1.15M
Mkt cap 844.79M
P/E 791.04
Div/yield     -
EPS 0.00
Shares 531.31M
Beta 1.23
Inst. own     -
Aug 13, 2014
ProMetic Life Sciences Inc at Canaccord Genuity Growth Conference
  

Key stats and ratios

Q2 (Jun '14) 2013
Net profit margin 530.81% -84.28%
Operating margin 530.76% -83.64%
EBITD margin - -45.13%
Return on average assets 107.18% -47.76%
Return on average equity 352.53% -122.43%
Employees 159 -
CDP Score - -

Address

Bldg 15, 531 Boul. des Prairies
LAVAL, QC H7V 1B7
Canada
+1-450-7810115 (Phone)
+1-450-7814477 (Fax)

Website links

Description

ProMetic Life Sciences Inc. (ProMetic) is a bio-pharmaceutical company offering technologies for large-scale drug purification, drug development, proteomics, clinical diagnostics, and the elimination of pathogens, The Company focuses its activities in two segments: protein technologies and therapeutics. It develops therapeutics to treat blood-related disorders. Its protein technologies are used to remove pathogens from blood and extract and recover proteins from plasma. The Company is developing products to treat anemia, neutropenia, cancer and autoimmune disease/inflammation. ProMetic uses its Affinity Technology, which employs its Mimetic Ligand technology (chemical hooks that selectively recognize and bind to target biomolecules) to facilitate a variety of applications, where a target biomolecule requires purification or removal. Effective May 9, 2014, the Company raised its interest to 60% from 10% by acquiring a 50% interest in NantPro Biosciences LLC.

Officers and directors

G. F. Kym Anthony Independent Chairman of the Board
Age: 58
Pierre Laurin Ph.D. President, Chief Executive Officer, Director
Bruce Pritchard Chief Financial Officer, Chief Operating Officer
Steven J. Burton Chief Executive Officer of ProMetic BioSciences Ltd.
Patrick Sartore General Counsel, Corporate Secretary
John Moran M.D. Chief Medical Officer, Director
Age: 68
Dwun-Hou Chen Ph.D. Senior Vice President, Product and Asia Pacific Development of ProMetic BioTherapeutics, Inc.
Stefan Clulow Director
Charles Kenworthy Director
Age: 56
Bruce J. Wendel Director
Age: 60